Related references
Note: Only part of the references are listed.Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
Shuichi Aoki et al.
GUT (2022)
Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
Yang Chen et al.
CANCER CELL (2021)
Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin
Zhanhuai Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Advances in immunotherapy for pancreatic ductal adenocarcinoma
Motoki Miyazawa et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
Jeff Yat-Fai Chung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balazs Gyorffy
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
Hyung-Don Kim et al.
HEPATOLOGY (2020)
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Cedric Zeltz et al.
SEMINARS IN CANCER BIOLOGY (2020)
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez et al.
CANCER DISCOVERY (2020)
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Nikita S. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Combining microenvironment normalization strategies to improve cancer immunotherapy
Fotios Mpekris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis
Clara Dees et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Activin-mediated alterations of the fibroblast transcriptome and matrisome control the biomechanical properties of skin wounds
Mateusz S. Wietecha et al.
NATURE COMMUNICATIONS (2020)
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer et al.
CANCER DISCOVERY (2020)
ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism
Sarah Theresa Boyle et al.
NATURE CELL BIOLOGY (2020)
Generalizing RNA velocity to transient cell states through dynamical modeling
Volker Bergen et al.
NATURE BIOTECHNOLOGY (2020)
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi et al.
EMBO MOLECULAR MEDICINE (2020)
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Xueke Shi et al.
BIOMOLECULES (2020)
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
John D. Martin et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)
A phase Ib dose-escalation and cohort-expansion study of safety and activity of the transforming growth factor (TGF) β receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.
Davide Melisi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis
Mi-Kyung Oh et al.
PLOS ONE (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
Laia Gorchs et al.
FRONTIERS IN IMMUNOLOGY (2019)
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
Eileen M. O'Reilly et al.
JAMA ONCOLOGY (2019)
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Multi-paratopic VEGF decoy receptor have superior anti-tumor effects through anti-EGFRs and targeted anti-angiogenic activities
Dae Hee Lee et al.
BIOMATERIALS (2018)
Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
Matthew A. Lakins et al.
NATURE COMMUNICATIONS (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Davide Melisi et al.
BRITISH JOURNAL OF CANCER (2018)
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
Liu-Ya Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease
Xi Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis
Hadi Khalil et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1
N. Cohen et al.
ONCOGENE (2017)
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Kelly L. Walton et al.
FRONTIERS IN PHARMACOLOGY (2017)
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S. Nagaraja et al.
JCI INSIGHT (2017)
Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma
Daniela Pankova et al.
MOLECULAR CANCER RESEARCH (2016)
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
Joao Incio et al.
CANCER DISCOVERY (2016)
Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumourchemoresistance
Camille Duluc et al.
EMBO MOLECULAR MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Panagiotis Papageorgis
JOURNAL OF ONCOLOGY (2015)
Novel Glycosylated VEGF Decoy Receptor Fusion Protein, VEGF-Grab, Efficiently Suppresses Tumor Angiogenesis and Progression
Jung-Eun Lee et al.
MOLECULAR CANCER THERAPEUTICS (2015)
CD133+ Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide
Sulagna Banerjee et al.
CLINICAL CANCER RESEARCH (2014)
Placental growth factor in cancer
Mieke Dewerchin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
Reng-Yun Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Interaction of Mesenchymal Stem Cells with Fibroblast-like Synoviocytes via Cadherin-11 Promotes Angiogenesis by Enhanced Secretion of Placental Growth Factor
Su-Jung Park et al.
JOURNAL OF IMMUNOLOGY (2014)
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation
Woosook Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
Matija Snuderl et al.
CELL (2013)
Wnt4/β-Catenin Signaling in Medullary Kidney Myofibroblasts
Derek P. DiRocco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
TGFβ signaling plays a critical role in promoting alternative macrophage activation
Dapeng Gong et al.
BMC IMMUNOLOGY (2012)
Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells
Y. Wang et al.
CURRENT MOLECULAR MEDICINE (2012)
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Inhibition of Placental Growth Factor Activity Reduces the Severity of Fibrosis, Inflammation, and Portal Hypertension in Cirrhotic Mice
Christophe Van Steenkiste et al.
HEPATOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: An experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy
Veerle F. Casneuf et al.
ONCOLOGY REPORTS (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
S Bamford et al.
BRITISH JOURNAL OF CANCER (2004)
Share Paper
